Breaking News Bar

Business News and Information

StemCells will shut down

StemCells Inc. (Nasdaq: STEM) terminated a mid-stage clinical trial and will wind down the company. The stock price plummeted $2.46 to close at $0.57.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear